NCT07288515Recruiting
Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus
Observational Prospective Study of Acalabrutinib in Chronic Lymphocytic Leukemia Therapy in Real Clinical Practice in Belarus.
Source: ClinicalTrials.gov · Last updated 9 Sept 2026
Brief summary (registry, in English)
to address critical gap in knowledge, providing essential data on the real-world effectiveness, safety, associated with acalabrutinib treatment in patients with CLL
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 31 Dec 2025
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- AstraZeneca
- Diseases
- Chronic lymphocytic leukaemia
- NCT number
- NCT07288515
What you commit to
- Study type: Observational
- Planned participants: 50
- From 31 Dec 2025 to the primary completion date, 31 Dec 2029
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior treatment with any BTK inhibitor.
Other
- Patients not satisfying any of the inclusion criteria.
- Participation in other ongoing clinical trials.
- Pregnant or breastfeeding females
Who the study is looking for
- Age ≥18 years.
- Confirmed diagnosis of CLL.
- Newly prescribed acalabrutinib monotherapy within the previous four weeks preceding study enrolment. Monotherapy is defined as acalabrutinib prescribes without concomitant administration (or planned initiation) of other anti-leukemic agents (e.g. obinutuzumab, venetoclax, bendamustine) within ± 30 days of acalabrutinib initiation.
- Treatment-naïve or R/R CLL.
- Ability and willingness to provide informed consent for study participation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Grodno | Belarus | Recruiting |
| - Coordinator of this site? Confirm its status | Homyel | Belarus | Not yet recruiting |
| - Coordinator of this site? Confirm its status | Minsk | Belarus | Recruiting |
| - Coordinator of this site? Confirm its status | Mogilev | Belarus | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.